Chris Dockendorff,Robert Flaumenhaft,Lawrence MacPherson
申请号：
US13825574
公开号：
US09422262B2
申请日:
2011.09.23
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention relates to the use of a compound of Formula I for the treatment of protease-activated receptor mediated diseases by the administration of a compound of Formula I or a prodrug or metabolite thereof.
